Correlation Between Blender Financial and Clal Biotechnology
Can any of the company-specific risk be diversified away by investing in both Blender Financial and Clal Biotechnology at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Blender Financial and Clal Biotechnology into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Blender Financial Technologies and Clal Biotechnology Industries, you can compare the effects of market volatilities on Blender Financial and Clal Biotechnology and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Blender Financial with a short position of Clal Biotechnology. Check out your portfolio center. Please also check ongoing floating volatility patterns of Blender Financial and Clal Biotechnology.
Diversification Opportunities for Blender Financial and Clal Biotechnology
0.31 | Correlation Coefficient |
Weak diversification
The 3 months correlation between Blender and Clal is 0.31. Overlapping area represents the amount of risk that can be diversified away by holding Blender Financial Technologies and Clal Biotechnology Industries in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Clal Biotechnology and Blender Financial is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Blender Financial Technologies are associated (or correlated) with Clal Biotechnology. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Clal Biotechnology has no effect on the direction of Blender Financial i.e., Blender Financial and Clal Biotechnology go up and down completely randomly.
Pair Corralation between Blender Financial and Clal Biotechnology
Assuming the 90 days trading horizon Blender Financial Technologies is expected to generate 1.44 times more return on investment than Clal Biotechnology. However, Blender Financial is 1.44 times more volatile than Clal Biotechnology Industries. It trades about 0.27 of its potential returns per unit of risk. Clal Biotechnology Industries is currently generating about -0.07 per unit of risk. If you would invest 36,030 in Blender Financial Technologies on November 3, 2024 and sell it today you would earn a total of 5,260 from holding Blender Financial Technologies or generate 14.6% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Together |
Strength | Very Weak |
Accuracy | 100.0% |
Values | Daily Returns |
Blender Financial Technologies vs. Clal Biotechnology Industries
Performance |
Timeline |
Blender Financial |
Clal Biotechnology |
Blender Financial and Clal Biotechnology Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Blender Financial and Clal Biotechnology
The main advantage of trading using opposite Blender Financial and Clal Biotechnology positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Blender Financial position performs unexpectedly, Clal Biotechnology can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Clal Biotechnology will offset losses from the drop in Clal Biotechnology's long position.Blender Financial vs. YD More Investments | Blender Financial vs. Oron Group Investments | Blender Financial vs. Magic Software Enterprises | Blender Financial vs. Discount Investment Corp |
Clal Biotechnology vs. Kamada | Clal Biotechnology vs. BioLine RX | Clal Biotechnology vs. Evogene | Clal Biotechnology vs. Bezeq Israeli Telecommunication |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Rebalancing module to analyze risk-adjusted returns against different time horizons to find asset-allocation targets.
Other Complementary Tools
Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals |